BioSpace

Sales of Johnson & Johnson’s esketamine-based nasal spray jumped in the fourth quarter last year, priming the pump for a suite of other pharmas, including AbbVie, champing at the bit with their own psychedelics. #psychedelics #spravato #biospace https://hubs.li/Q0426WQT0

With Biogen's multiple sclerosis portfolio facing more generic pressure than ever, the company is eyeing a busy late-stage pipeline and hunting for deals to build its return to growth. #drugpipeline #pharma #biospace https://hubs.li/Q0426XQw0

Charles River Laboratories is shutting down a cell therapy site, affecting 20 employees, while Thermo Fisher Scientific is winding down operations at a production plant, impacting 103 staffers. Learn more in our layoff tracker. #layoffs #biopharma #biospace https://hubs.li/Q0425PcF0

According to Priovant, the Phase 2 BEACON study is the first industry-sponsored placebo-controlled trial in cutaneous sarcoidosis to deliver positive data. #pharma #biospace https://hubs.li/Q0425G1n0

Novo Nordisk has also spoken out strongly against Hims & Hers’ compounded Wegovy pill, with CEO Maziar Mike Doustdar telling investors the knockoff version is a waste of money. #GLP1 #weightloss #biospace https://hubs.li/Q0425D380

Biopharma talent is rethinking their next move: 85% are considering roles outside biopharma. Uncover the motivations, trends, and implications in our 2026 Employment Outlook. 🔗 Download here: https://hubs.li/Q041xCVd0

Biopharma’s obsession with the weight loss sector—projected to exceed $130 billion in revenue by 2035—shows no signs of slowing down as analysts gear up for a year that will test the oral market and provide key data on novel mechanisms. #biopharma #obesity #weightloss #opinion #biospace https://hubs.ly/Q0425D6t0

The administration’s direct-to-consumer pharmaceutical sales platform will offer products from Eli Lilly and Company, Pfizer, Novo Nordisk, Amgen and more at a discount, though the impact of such pricing remains to be seen. #drugpricing #trumprx #biospace https://hubs.ly/Q0425CWj0

Bristol Myers Squibb delivered better than expected fourth quarter earnings, but Eliquis missed expectations while Cobenfy continues to struggle with uptake. #earnings #pharma #biospace https://hubs.li/Q0421tl90

Novo Nordisk and Eli Lilly and Company have been battling head-to-head in an exploding obesity market. They should never have been compared apples to apples. #editorial #obesity #biospace https://hubs.li/Q0421pBL0